Immunoprecipitation of Reporter Nascent Chains from Active Ribosomes to Study Translation Efficiency

Materials and reagents

Biological materials

1. Human osteosarcoma epithelial cell line (U2OS) or other cell lines

2. Plasmids expressing 3× Flag-tagged reporter protein flanked by UTRs of interest from Cacioppo et al. (2023).

3. RT-qPCR forward (CTGACCCTGAAGCTGATCT) and reverse (GCATGGCGGACTTGAAGAAG) primers targeting the Venus coding sequence on the reporter mRNA

   
   

Reagents

1. Cell culture medium [DMEM supplemented with 10% fetal bovine serum (FBS), 200 μM GlutaMAX-1, 100 U/mL penicillin, 100 μg/mL streptomycin, and 250 ng/mL fungizone] or other media as appropriate for the selected cell line

2. Phosphate-buffered saline (PBS) (Severn Biotech, catalog number: 207410)

3. Trypsin/EDTA solution (VWR, catalog number: LZBE02-007E)

4. Neon transfection system 100 μL kit (Thermo Fisher Scientific, catalog number: MPK10025)

5. Hanks’ balanced salt solution (HBSS) (Hyclone, catalog number: 10739674)

6. RNaseZap (Sigma, catalog number: R2020)

7. UltraPure DNase/RNase-free distilled water (Thermo Fisher Scientific, catalog number: 10977035)

8. Protector RNase inhibitor (Roche, catalog number: 3335399001)

9. EDTA (Invitrogen, catalog number: 10458654)

10. Complete Mini EDTA-free protease inhibitor (Roche, catalog number: 11836170001)

11. Tris-HCl pH 7.5 (Fisher Scientific, catalog number: BP1757-100)

12. Lithium chloride (LiCl) (Sigma, catalog number: L7026)

13. Tris-buffered saline (TBS) (Sigma, catalog number: T5912)

14. Cycloheximide (CHX) (Sigma, catalog number: 01810)

15. Triton X-100 (VWR, catalog number: 28817.295)

16. Anti-Flag M2 magnetic beads (Sigma, catalog number: M8823)

17. Puromycin (Alfa Aesar, catalog number: J67236.XF)

18. 3× Flag peptide (Sigma, catalog number: F4799)

19. Ethanol (absolute) (Sigma, catalog number: 24105-2.5L-M)

20. Luna Universal One-Step RT-qPCR kit (NEB, catalog number: E3005S)

21. Monarch RNA Cleanup kit (NEB, catalog number: T2040L)

    
    

Solutions

1. 3× Flag peptide elution buffer (manufacturer’s instructions)

2. Lysis buffer (see Recipes)

3. Wash buffer (see Recipes)

4. Puromycin elution buffer (see Recipes)

   
   

Recipes

Critical: Prepare all solutions in RNase-free conditions.

Note: All solutions should be prepared fresh. However, buffers can be stored at 4 °C, provided that some reagents are added just before the relative experimental step (denoted with “*”).

1. Lysis buffer

   Reagent	Final concentration	Quantity
   Tris-HCl (1 M, pH 7.5)	100 mM	250 μL
   LiCl (8 M)	500 mM	156 μL
   EDTA (0.5 M)	10 mM	50 μL
   CHX (20 mg/mL)*	0.1 mg/mL	12.5 μL
   Triton X-100 (10%)	0.1%	25 μL
   Protease inhibitor*	1×	Dissolve ¼ tablet directly in lysis buffer
   Protector RNase inhibitor (40 U/μL)*	0.1 U/μL	6.25 μL
   H2O	n/a	2 mL
   Total	n/a	2.5 mL

   
   

2. Wash buffer

   Reagent	Final concentration	Quantity
   Tris-HCl (1 M, pH 7.5)	10 mM	30 μL
   LiCl (8 M)	600 mM	225 μL
   EDTA (0.5 M)	1 mM	6 μL
   CHX (20 mg/mL)*	0.1 mg/mL	15 μL
   Protector RNase inhibitor (40 U/μL)*	0.1 U/μL	7.5 μL*
   H2O	n/a	2,717 μL
   Total	n/a	3 mL

   
   

3. Puromycin elution buffer

   Reagent	Final concentration	Quantity
   Tris-HCl (1 M, pH 7.5)	10 mM	6 μL
   LiCl (8 M)	600 mM	45 μL
   EDTA (0.5 M)	1 mM	1.2 μL
   Protector RNase inhibitor (40 U/μL)*	0.1 U/μL	1.5 μL*
   Puromycin (200 μM)	20 mM	6 μL
   H2O	n/a	540 μL
   Total	n/a	600 μL

   
   

Laboratory supplies

1. Ice

2. Tissue culture dishes (15 cm) (Nunc, catalog number: 168381)

3. Tissue culture dishes (10 cm) (Nunc, catalog number: 150350)

4. Sterile pipette filter tips (10, 200, 1,000 μL) (Starlab, catalog number: S1122)

5. 10 mL plastic pipettes (Fisher Scientific, catalog number: 11839660)

6. 50 mL centrifuge tubes (Greiner, catalog number: 227285)

7. Sterile and RNase-free 1.5 mL centrifuge tubes

8. Cell scrapers (Fisher, catalog number: 11597692)

9. 96-well reaction plates (Thermo Fisher Scientific, catalog number: 4346906)

10. Optical adhesive films (Thermo Fisher Scientific, catalog number: 4360954)

Equipment

1. Pipettes (10 μL, 200 μL, 1,000 μL) (Gilson)

2. Pipetboy (Integra)

3. Centrifuge (Thermo Fisher Scientific, catalog number: 15868722)

4. MiniSpin centrifuge (Eppendorf, catalog number: 5452000060)

5. Neon Transfection System (Thermo Fisher Scientific, catalog number: MPK5000)

6. Neon Transfection System Pipette (Thermo Fisher Scientific, catalog number: MPP100)

7. Micro-volume spectrophotometer NanoDrop^TM Lite (Thermo Fisher Scientific)

8. Tube rotator (Fisherbrand, catalog number: 88861050)

9. Magnetic rack (Invitrogen)

10. StepOnePlus Real-Time PCR System (Applied Biosystems, catalog number: 4376600)

11. Ice buckets

12. 4 °C fridge and -20 °C freezer

Software and datasets

Microsoft Excel (Microsoft Corporation) for analysis of RT-qPCR data and creation of graphs. Can be substituted by R or any other software for data analysis.

Procedure

The protocol here presented is designed for analysis of three conditions in a single experiment. If a different number of conditions is required, adapt volumes accordingly. A flowchart of the procedures is shown in Figure 1. See General note 1.

Figure 1. Overview of the protocol steps

1. Seed 1 × 10⁶ cells onto a 15 cm dish per condition such that cells are confluent after 24 h

   
   

2. Electroporation

   Note: Carry out all procedures under a laminar flow hood and follow standard tissue culture procedures.

   1. Prepare materials for the electroporation.

      1. Place medium, trypsin, and HBSS solutions at 37 °C.

      2. Place the electroporation tube into the holder in the Neon Electroporation machine.

      3. Pipette 3 mL of E2 electrolytic buffer from Neon transfection system kit into the electroporation tube.

      4. Prepare 3 × 1.5 mL tubes containing 1 mL of cell medium and keep at 37 °C. These are required later to enable recovery of cells following electroporation.

      5. Prepare 3 × 1.5 mL tubes each containing 3–5 μg of plasmid DNA.

      6. Prepare 3 × 1.5 mL tubes containing 1 mL of PBS. These are required later to rinse the electroporation pipette tip before moving to the next electroporation condition.

      7. Select the transfection program: voltage 1,150 V, width 30 ms, 2 pulses.

      8. Attach a gold electroporation tip to the electroporation pipette.

   2. Detach cells from 15 cm plates.

      1. Remove medium and wash cells in 10 mL of PBS.

      2. Remove PBS and add 1.5 μL of warm trypsin.

      3. Incubate at 37 °C for 3–5 min and then add 15 mL of warm medium.

   3. Transfer cells to a 50 mL Falcon tube.

   4. Centrifuge at 200× g for 3 min at room temperature.

   5. Wash cells in 10 mL of PBS and centrifuge again at 200× g for 3 min.

   6. Remove PBS and wash again in 1 mL of PBS, transferring cells to 1.5 mL tubes.

   7. Centrifuge using MiniSpin at 300× g for 1 min at room temperature.

   8. Remove PBS and equilibrate cells in HBSS by resuspending cell pellet in 1 mL of warm HBSS.

   9. Centrifuge using MiniSpin at 300× g for 1 min.

   10. Resuspend cells in 330 μL of warm HBSS and transfer into appropriate tube with plasmid DNA.

       Note: Electroporation is performed in three rounds per condition. For this, use 100 μL per electroporation round plus excess to avoid formation of bubbles during pipetting.

       Caution: Air bubbles could cause arcing during electroporation.

   11. Use the electroporation pipette to transfer cells to the Neon electroporation tube. Perform electroporation. Transfer electroporated cells to 1.5 mL tube with 1 mL of warm medium. Gently invert tube and place at 37 °C. Caution: When pipetting electroporated cells into tube with warm medium, avoid contact between the pipette tip and the medium as this could cause arcing due to presence of FBS in the medium.

   12. Repeat step B11 two more times for the same condition.

   13. Before moving to the next condition, rinse the electroporation pipette tip in PBS multiple times.

   14. Centrifuge electroporated cells using MiniSpin at 300× g for 1 min.

   15. Resuspend in 1 mL of warm medium, plate in 10 cm dishes (one dish per condition) with final 10 mL of medium and incubate at 37 °C for 24 h.

   16. Clean and dispose of electroporation kit components according to the manufacturer’s instructions. Critical: At sections C–F, strictly follow standard procedures for handling RNA. Treat work surfaces and pipettes with 70% ethanol and RNaseZap. Carry out all procedures on ice and always keep samples and solutions on ice. See General note 2.

       
       

3. Cell lysis

   1. Prepare solutions.

      1. 35 mL of PBS + CHX 0.1 mg/mL

      1. 2.5 mL of lysis buffer

      2. 1.2 mL of TBS 1×

   2. Add CHX at a final concentration of 0.1 mg/mL to electroporated cells and incubate at 37 °C for 15 min.

   3. Place plate on ice and wash cells once quickly with 10 mL of ice-cold PBS + CHX 0.1 mg/mL.

   4. Scrape quickly in 1 mL of ice-cold PBS + CHX 0.1 mg/mL while keeping plate on ice.

   5. Transfer cells into 1.5 mL tubes and centrifuge using MiniSpin at 300× g for 5 min at 4 °C.

   6. Resuspend cell pellets in 200 μL of ice-cold lysis buffer and incubate on ice for 15 min.

   7. Centrifuge using MiniSpin at 12,000× g for 15 min at 4 °C.

   8. Transfer 180 μL of supernatants (Input) into new 1.5 mL tubes.

      Note: Transfer less than 200 μL of supernatant to avoid collection of pelleted material.

   9. Make a 10 μL aliquot for RNA isolation. Keep at 4 °C and perform RNA isolation (see section E) at the same time as the eluted RNA (see section D, steps 9–10).

      
      

4. Immunoprecipitation

   Note: Use 40 μL of beads slurry per condition. Beads need to be mixed to achieve a homogenous suspension. Handle beads according to the manufacturer’s instructions. Use a magnetic rack to separate beads from solutions.

   1. Transfer 120 μL of beads slurry to a 1.5 mL tube. Remove solution in which beads were stored.

   2. Wash beads twice in 600 μL of ice-cold TBS 1×.

      Note: Gently invert tube 4–5 times to wash beads.

   3. Add 750 μL of ice-cold lysis buffer and split equally into 3 × 1.5 mL tubes.

   4. Add 170 μL of Input samples to respective tube containing beads.

   5. Incubate tubes at 4 °C overnight gently rotating at 10–30 rpm.

   6. Prepare solutions.

      1. 3 mL of wash buffer.

      2. 600 μL of puromycin elution buffer or 600 μL of 3× Flag peptide elution buffer.

   7. Discard supernatants (flowthrough).

   8. Wash beads twice with 0.5 mL of ice-cold wash buffer.

      Note: Gently invert tube 4–5 times to wash beads.

   9. Perform elution. See General note 3.

      1. Elution by puromycin: add 200 μL of puromycin elution buffer to each tube containing beads and incubate at 4 °C for 30 min gently rotating at 10–30 rpm. Collect Elution samples and keep on ice for RNA isolation to be performed straight after.

         or

      2. Elution by 3× Flag peptide: add 100 μL of 3× Flag peptide elution buffer to each tube containing beads and incubate at 4 °C for 30 min gently rotating at 10–30 rpm. Collect eluates and repeat step. Collect eluates again and pool with previous respective eluates (total volume of elution samples 200 μL). Keep on ice for RNA isolation to be performed straight after.

   10. Perform RNA purification as in section E.

       
       

5. RNA isolation

   1. Isolate RNA using Monarch RNA Cleanup kit according to the manufacturer’s instructions. These include a step of DNA digestion. Elute in 30 μL of ice-cold nuclease-free H₂O.

   2. Assess RNA concentration and purity using the NanoDrop.

   3. Add EDTA at final concentration between 0.1 and 1 mM to samples.

      Note: This is optional. However, addition of EDTA may reduce the activity of any contaminating RNases. Make sure that EDTA is compatible with both the RNA isolation method and the reagents for downstream RT-qPCR.

      Pause Point: Purified Input and Elution samples can be stored at -80 °C long term.

      
      

6. One-step RT-qPCR

   See General note 4.

   1. Thaw RT-qPCR kit components, primers, and purified RNA samples on ice.

   2. Prepare a reaction master mix according to the manufacturer’s instructions. For three conditions, prepare the equivalent of 20 reactions (includes one extra reaction to account for pipetting errors).

      Note: Quickly vortex and spin all reaction reagents before use.

   3. Distribute master mix to 19 wells of a 96-well plate.

   4. Distribute each RNA sample to three wells.

   5. Add a volume of H₂O equivalent to the volume of RNA samples in a single well to the well corresponding to the no-template control reaction. Critical: Avoid formation of bubbles while pipetting during steps F3–F4. This might interfere with the amplification reaction.

   6. Cover plate with optical adhesive film.

   7. Quickly spin the plate to collect drops at the bottom of wells and to remove potential bubbles.

   8. Cover plate with darkening foil while setting up RT-qPCR machine.

   9. Load plate onto the RT-qPCR machine and start reaction. Perform one-step RT-qPCR according to the manufacturer’s instructions.

Data analysis

Translation efficiency (TE) is calculated using the percent input method, which compares the amount of target mRNA measured in the Elution fraction to the total amount of the target mRNA in the Input fraction. For this, first the ∆Cq is calculated as follows:

∆Cq = Cq(Elution) - [Cq(Input) - Log₂(DF)]

where DF is dilution factor (e.g., if 5% of total Input is used for RT-qPCR, the DF is 20). TE of reporter mRNA is then calculated as:

% Input = 100 × 2^-∆Cq

Representative data can be found in Figure 2. For each experiment, three technical replicates and three repeats of the experiment should be performed. Appropriate controls for the experiment should be used, like using an untagged reporter protein (see Cacioppo et al., 2023) or untransfected cells.

Representative data

Figure 2. Quantification by RT-qPCR of indicated reporter mRNAs in an experiment designed to test the role of different 3′ untranslated regions (UTR) configurations (D, L, S) of Aurora kinase A (AURKA), eluted via puromycin (left) or 3× Flag peptide (right). Results representative of three repeats of the experiment. See Cacioppo et al., 2023 for details of the experiment.

Validation of protocol

This protocol was validated in Cacioppo et al. (2023). eLife. Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A.

General notes and troubleshooting

General notes

1. Other standard procedures for transfection (e.g., lipofectamine transfection) and cell lysis can be used. Number of cells to transfect per condition should be adapted to transfection efficiency or to the estimated expression levels of the reporter protein and determined empirically for the selected cell type. The cultures should be sub-confluent on the day of harvesting to avoid contact inhibition of translation. Furthermore, in some cell types and under particular states (e.g., genotoxic or proteotoxic stress), ribosomes may exist in stalled forms, suggesting that association of mRNA with ribosomes may not be indicative of active translation in these cases.

2. Make sure to optimise conditions. As for any procedure that involves handling and quantifying RNA, empirical tests may be required to find optimal conditions. Alternative methods of RNA isolation and RT-qPCR kits could be used, but conditions must be optimised accordingly.

3. To read about the action of puromycin, consult Blobel and Sabatini (1971) and Aviner (2020). It is important to note that, although being cost efficient and potentially eluting cleaner RNA, puromycin-induced release of ribosomes may be more variable upon conditions as salt, temperature, ribosome state, presence of CHX, or nucleic or amino acid sequence motifs, than 3× Flag-mediated elution. For this, it is recommended to initially test both elution methods in parallel, in order to find the more suitable for one’s own experimental aims and conditions.

4. It is highly recommended to perform RT-qPCR as soon as possible, to avoid alterations in the composition of the RNA extracts due to eventual RNA degradation. The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines (Bustin et al., 2009) should be followed when performing RT-qPCR experiments. One-step RT-qPCR can be replaced by sequential cDNA synthesis and RT-qPCR.

5. To control for efficiency of IP and for optimization purposes, RT-qPCR could be performed with primers to housekeeping genes (e.g., ACTB, GAPDH). In addition, RNA can be isolated from the Flowthrough, as well, and analysed in parallel with Input and Elution samples.

6. The assay could be adapted to immunoprecipitate nascent chains using other tags different from Flag tag. Use of small peptide tags is recommended to minimise possible influences on translation efficiency.

7. It is important to note that cell lysates typically contain a higher ratio of mature to nascent reporter protein. Although we have no evidence of this, it may be possible that the mature reporter protein interacts with ribosomes or mRNA outside the context of active translation (e.g., in RNA granules), and this could interfere with the interpretation of results. Furthermore, reporter expression levels will depend on transfection yield, overall translation rates, and time from transfection to harvesting. Therefore, the conditions should be determined empirically. A small-scale transfection experiment could be performed, harvesting samples at multiple time points, and measuring expression by anti-Flag immunoblotting.

   
   

   Troubleshooting (see Table 1)

   
   

   Table 1. Troubleshooting

   Issue	Probable cause	Possible Solution
   Low RNA yield	RNase contamination	• Ensure all instruments, workspaces, and reagents are RNase-free. • Change gloves routinely. • Use filtered pipette tips. • Pre-chill all tubes and buffers before use. • Increase volume of RNase inhibitor. • Perform procedures under a laminar flow hood.
   Low IP efficiency (see General note 5)	Low electroporation efficiency	• Make sure to warm medium and solutions at 37 °C. • Make sure cells are not stressed, damaged, or contaminated by Mycoplasma. Cell density should not be too low or too high and fresh cultures should be used. • Make sure plasmids have high degree of purity and that a volume < 1/10 of volume of the cell suspension is used. • Electroporation conditions (voltage, width, pulses) might need to be optimised, especially if using a different cell line.
   	Immunoprecipitated target RNA is too low	• Combine Elution RNA samples from multiple technical replicates. • Increase amount of beads slurry. • Increase stringency of washes. • Increase duration of the elution step.
   	Low purity of Input/Eluted RNA	• Increase volume of RNase inhibitor. • Make sure samples are not contaminated by genomic DNA.
   	Non-specific binding to beads	• Increase stringency of washes. • Decrease volume of lysate used. • Coat beads with bovine serum albumin prior to IP.
   	Issues with RT-qPCR	• Make sure primers are designed to be optimal. Primer pairs should have amplification efficiency of 90%–110%. • Make sure pipetting is consistent and accurate. • Follow RT-qPCR kit manufacturer’s instructions on maximum amount of template RNA to use per reaction. • General RT-qPCR troubleshooting applies.

Acknowledgments

We are grateful to members of the Lindon Lab and to the staff of Department of Pharmacology for technical support. This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) (grant no. BB/R004137/1) to CL. RC is supported by David James Studentship from the Department of Pharmacology. The protocol was inspired by a method developed by Williams et al., 2022. The corresponding original research article is Cacioppo et al. (2023). Graphical overview was created with BioRender.com.

Competing interests

There are no conflicts of interest or competing interests.

References

1. Aviner, R. (2020). The science of puromycin: From studies of ribosome function to applications in biotechnology. Comput. Struct. Biotechnol. J. 18: 1074–1083.
2. Aviner, R., Geiger, T. and Elroy-Stein, O. (2013). Novel proteomic approach (PUNCH-P) reveals cell cycle-specific fluctuations in mRNA translation. Genes Dev. 27(16): 1834–1844.
3. Biswas, J., Liu, Y., Singer, R. H. and Wu, B. (2019). Fluorescence Imaging Methods to Investigate Translation in Single Cells. Cold Spring Harbor Perspect. Biol. 11(4): a032722.
4. Blanchet, S. and Ranjan, N. (2022). Translation Phases in Eukaryotes.In: Entian, KD. (Ed.). Ribosome Biogenesis (pp. 217–228). Methods in Molecular Biology. Humana, New York.
5. Blobel, G. and Sabatini, D. (1971). Dissociation of Mammalian Polyribosomes into Subunits by Puromycin. Proc. Natl. Acad. Sci. U. S. A. 68(2): 390–394.
6. Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009). The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments. Clin. Chem. 55(4): 611–622.
7. Cacioppo, R., Akman, H. B., Tuncer, T., Erson-Bensan, A. E. and Lindon, C. (2023). Differential translation of mRNA isoforms underlies oncogenic activation of cell cycle kinase Aurora A. eLife 12: e87253.
8. Guttman, M., Russell, P., Ingolia, N. T., Weissman, J. S. and Lander, E. S. (2013). Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins. Cell 154(1): 240–251.
9. Hinnebusch, A. G., Ivanov, I. P. and Sonenberg, N. (2016). Translational control by 5’-untranslated regions of eukaryotic mRNAs. Science 352(6292): 1413–1416.
10. Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S. and Weissman, J. S. (2009). Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling. Science 324(5924): 218–223.
11. Ingolia, N. T., Brar, G. A., Stern-Ginossar, N., Harris, M. S., Talhouarne, G. J., Jackson, S. E., Wills, M. R. and Weissman, J. S. (2014). Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes. Cell Rep. 8(5): 1365–1379.
12. Liang, S., Bellato, H. M., Lorent, J., Lupinacci, F. C. S., Oertlin, C., van Hoef, V., Andrade, V. P., Roffé, M., Masvidal, L., Hajj, G. N. M. and Larsson, O. (2018). Polysome-profiling in small tissue samples. Nucleic Acids Res. 46(1): E3.
13. Mayr, C. (2019). What Are 3’ UTRs Doing?. Cold Spring Harbor Perspect. Biol. 11(10): a034728.
14. Raue, U., Oellerer, S. and Rospert, S. (2007). Association of Protein Biogenesis Factors at the Yeast Ribosomal Tunnel Exit Is Affected by the Translational Status and Nascent Polypeptide Sequence. J. Biol. Chem. 282(11): 7809–7816.
15. Renz, P. F., Valdivia-Francia, F. and Sendoel, A. (2020). Some like it translated: small ORFs in the 5′UTR. Exp. Cell. Res. 396(1): 112229.
16. Williams, T. D., Cacioppo, R., Agrotis, A., Black, A., Zhou, H. and Rousseau, A. (2022). Actin remodelling controls proteasome homeostasis upon stress. Nat. Cell Biol. 24(7): 1077–1087.
17. Zhang, Y., Wölfle, T. and Rospert, S. (2013). Interaction of Nascent Chains with the Ribosomal Tunnel Proteins Rpl4, Rpl17, and Rpl39 of Saccharomyces cerevisiae. J. Biol. Chem. 288(47): 33697–33707.